Generation and Characterization of a CYP2C11-Null Rat Model by Using the CRISPR/Cas9 Method | |
Wei, Yuan[1]; Yang, Li[2]; Zhang, Xiaoyan[3]; Sui, Danjuan[4]; Wang, Changsuo[5]; Wang, Kai[6]; Shan, Mangting[7]; Guo, Dayong[8]; Wang, Hongyu[9] | |
刊名 | DRUG METABOLISM AND DISPOSITION |
2018 | |
卷号 | 46期号:5页码:525-531 |
ISSN号 | 0090-9556 |
DOI | http://dx.doi.org/10.1124/dmd.117.078444 |
URL标识 | 查看原文 |
收录类别 | SCI(E) ; PUBMED |
WOS记录号 | WOS:000437363300005 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5337748 |
专题 | 江苏大学 |
作者单位 | 1.[1]Jiangsu Univ, Sch Pharm, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 2.[2]Jiangsu Univ, Sch Pharm, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 3.[3]Jiangsu Univ, Sch Pharm, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 4.[4]Jiangsu Univ, Sch Pharm, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 5.[5]Jiangsu Univ, Sch Pharm, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 6.[6]Jiangsu Univ, Sch Pharm, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China. 7.[7]MtC BioPharma Co Ltd, Nanjing, Jiangsu, Peoples R China. 8.[8]Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China. 9.[9]Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China. |
推荐引用方式 GB/T 7714 | Wei, Yuan[1],Yang, Li[2],Zhang, Xiaoyan[3],et al. Generation and Characterization of a CYP2C11-Null Rat Model by Using the CRISPR/Cas9 Method[J]. DRUG METABOLISM AND DISPOSITION,2018,46(5):525-531. |
APA | Wei, Yuan[1].,Yang, Li[2].,Zhang, Xiaoyan[3].,Sui, Danjuan[4].,Wang, Changsuo[5].,...&Wang, Hongyu[9].(2018).Generation and Characterization of a CYP2C11-Null Rat Model by Using the CRISPR/Cas9 Method.DRUG METABOLISM AND DISPOSITION,46(5),525-531. |
MLA | Wei, Yuan[1],et al."Generation and Characterization of a CYP2C11-Null Rat Model by Using the CRISPR/Cas9 Method".DRUG METABOLISM AND DISPOSITION 46.5(2018):525-531. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论